First-line treatment of driver gene-negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab?
Article in Investigational New Drugs (February 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Investigational New Drugs (February 2024)
Article in Chinese Journal of Oncology (January 2024)
Preprint in Research Square (September 2023)